Skip to main content

Open Science And A Robust IP Strategy: Life Sciences Can Do Both

News


Abstract

As biotech companies face decreasing productivity, they need ways to do more with less, and fast. A fresh approach to achieve this is by rethinking how innovation is structured: collaborate early and openly, protect intellectual property (IP) later.
Key Data

  • Publication Date
    28 July 2025
  • Primary Author
    Richard Gold
  • Source
    lifescienceleader.com
  • Language
    English
Click below to visit original source: